Body weight and prolactinoma: A retrospective study

International Journal of Obesity

Volumn 28, Issue 1, 2004, Pages 183-

  Soran, H ^a   Wilding, J ^a   MacFarlane, I ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PROLACTIN; THYROXINE;

BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSULTATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS FUNCTION; LETTER; MALE; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROLACTINOMA; RETROSPECTIVE STUDY; TUMOR VOLUME; WEIGHT GAIN;

BODY WEIGHT; FEMALE; HUMANS; MALE; PROLACTINOMA; RETROSPECTIVE STUDIES;

EID: 0942290484     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802492     Document Type: Letter

References (5)

1. Cohen LM, Greenberg DB, Murray GB. Neuropsychiatric presentation of men with pituitary tumours. Psychosomatics 1984; 25: 925-928.
2. Creemers PM, Zelissen PMJ, van't Verlaat JW, Koppeschaar HPF. Prolactinoma and body weight: a retrospective study. Acta Endocrinol 1991; 125: 392-396.
3. Greenman Y, Tordjman K, Stern N. Increased body weight associated with prolactin secreting pituitary adenomas; weight loss with normalization of prolactin levels. Clin Endocrinol 1998; 48: 547-553.
4. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popavic V. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002; 147: 77-84.
5. Delgrange E, Donckier J, Maiter D. Hyperprolactinaemia as a reversible cause of weight gain in male patients? Clin Endocrinol 1999; 50: 271.